id	sid	tid	token	lemma	pos
cord-266423-s8lqdpvn	1	1	key	key	JJ
cord-266423-s8lqdpvn	1	2	:	:	:
cord-266423-s8lqdpvn	1	3	cord-266423-s8lqdpvn	cord-266423-s8lqdpvn	JJ
cord-266423-s8lqdpvn	1	4	authors	author	NNS
cord-266423-s8lqdpvn	1	5	:	:	:
cord-266423-s8lqdpvn	1	6	Jose	Jose	NNP
cord-266423-s8lqdpvn	1	7	,	,	,
cord-266423-s8lqdpvn	1	8	Ricardo	Ricardo	NNP
cord-266423-s8lqdpvn	1	9	J.	J.	NNP
cord-266423-s8lqdpvn	1	10	;	;	:
cord-266423-s8lqdpvn	1	11	Manuel	Manuel	NNP
cord-266423-s8lqdpvn	1	12	,	,	,
cord-266423-s8lqdpvn	1	13	Ari	Ari	NNP
cord-266423-s8lqdpvn	1	14	title	title	NN
cord-266423-s8lqdpvn	1	15	:	:	:
cord-266423-s8lqdpvn	1	16	Does	do	VBZ
cord-266423-s8lqdpvn	1	17	Coronavirus	Coronavirus	NNP
cord-266423-s8lqdpvn	1	18	Disease	Disease	NNP
cord-266423-s8lqdpvn	1	19	2019	2019	CD
cord-266423-s8lqdpvn	2	1	Disprove	disprove	VB
cord-266423-s8lqdpvn	2	2	the	the	DT
cord-266423-s8lqdpvn	2	3	Obesity	Obesity	NNP
cord-266423-s8lqdpvn	2	4	Paradox	Paradox	NNP
cord-266423-s8lqdpvn	2	5	in	in	IN
cord-266423-s8lqdpvn	2	6	Acute	acute	JJ
cord-266423-s8lqdpvn	2	7	Respiratory	respiratory	JJ
cord-266423-s8lqdpvn	2	8	Distress	Distress	NNP
cord-266423-s8lqdpvn	2	9	Syndrome	Syndrome	NNP
cord-266423-s8lqdpvn	2	10	?	?	.
cord-266423-s8lqdpvn	3	1	date	date	NN
cord-266423-s8lqdpvn	3	2	:	:	:
cord-266423-s8lqdpvn	3	3	2020	2020	CD
cord-266423-s8lqdpvn	3	4	-	-	HYPH
cord-266423-s8lqdpvn	3	5	05	05	CD
cord-266423-s8lqdpvn	3	6	-	-	HYPH
cord-266423-s8lqdpvn	3	7	22	22	CD
cord-266423-s8lqdpvn	3	8	journal	journal	NN
cord-266423-s8lqdpvn	3	9	:	:	:
cord-266423-s8lqdpvn	3	10	Obesity	obesity	NN
cord-266423-s8lqdpvn	3	11	(	(	-LRB-
cord-266423-s8lqdpvn	3	12	Silver	Silver	NNP
cord-266423-s8lqdpvn	3	13	Spring	Spring	NNP
cord-266423-s8lqdpvn	3	14	)	)	-RRB-
cord-266423-s8lqdpvn	3	15	DOI	DOI	NNP
cord-266423-s8lqdpvn	3	16	:	:	:
cord-266423-s8lqdpvn	4	1	10.1002	10.1002	CD
cord-266423-s8lqdpvn	4	2	/	/	SYM
cord-266423-s8lqdpvn	4	3	oby.22835	oby.22835	NNP
cord-266423-s8lqdpvn	4	4	sha	sha	NNP
cord-266423-s8lqdpvn	4	5	:	:	:
cord-266423-s8lqdpvn	4	6	d10f1b0c7f824287a018961ddf88c46e5cc0c9a1	d10f1b0c7f824287a018961ddf88c46e5cc0c9a1	NFP
cord-266423-s8lqdpvn	4	7	doc_id	doc_id	CD
cord-266423-s8lqdpvn	4	8	:	:	:
cord-266423-s8lqdpvn	4	9	266423	266423	CD
cord-266423-s8lqdpvn	4	10	cord_uid	cord_uid	NNS
cord-266423-s8lqdpvn	4	11	:	:	:
cord-266423-s8lqdpvn	5	1	s8lqdpvn	s8lqdpvn	NNP
cord-266423-s8lqdpvn	5	2	Obesity	obesity	NN
cord-266423-s8lqdpvn	5	3	is	be	VBZ
cord-266423-s8lqdpvn	5	4	associated	associate	VBN
cord-266423-s8lqdpvn	5	5	with	with	IN
cord-266423-s8lqdpvn	5	6	a	a	DT
cord-266423-s8lqdpvn	5	7	decrease	decrease	NN
cord-266423-s8lqdpvn	5	8	in	in	IN
cord-266423-s8lqdpvn	5	9	mortality	mortality	NN
cord-266423-s8lqdpvn	5	10	in	in	IN
cord-266423-s8lqdpvn	5	11	patients	patient	NNS
cord-266423-s8lqdpvn	5	12	with	with	IN
cord-266423-s8lqdpvn	5	13	Adult	Adult	NNP
cord-266423-s8lqdpvn	5	14	Respiratory	Respiratory	NNP
cord-266423-s8lqdpvn	5	15	Distress	Distress	NNP
cord-266423-s8lqdpvn	5	16	Syndrome	Syndrome	NNP
cord-266423-s8lqdpvn	5	17	(	(	-LRB-
cord-266423-s8lqdpvn	5	18	ARDS	ARDS	NNP
cord-266423-s8lqdpvn	5	19	)	)	-RRB-
cord-266423-s8lqdpvn	5	20	and	and	CC
cord-266423-s8lqdpvn	5	21	is	be	VBZ
cord-266423-s8lqdpvn	5	22	referred	refer	VBN
cord-266423-s8lqdpvn	5	23	to	to	IN
cord-266423-s8lqdpvn	5	24	as	as	IN
cord-266423-s8lqdpvn	5	25	the	the	DT
cord-266423-s8lqdpvn	5	26	obesity	obesity	NN
cord-266423-s8lqdpvn	5	27	paradox.1	paradox.1	NNS
cord-266423-s8lqdpvn	5	28	ARDS	ARDS	NNP
cord-266423-s8lqdpvn	5	29	is	be	VBZ
cord-266423-s8lqdpvn	5	30	a	a	DT
cord-266423-s8lqdpvn	5	31	type	type	NN
cord-266423-s8lqdpvn	5	32	of	of	IN
cord-266423-s8lqdpvn	5	33	respiratory	respiratory	JJ
cord-266423-s8lqdpvn	5	34	failure	failure	NN
cord-266423-s8lqdpvn	5	35	characterised	characterise	VBN
cord-266423-s8lqdpvn	5	36	by	by	IN
cord-266423-s8lqdpvn	5	37	rapid	rapid	JJ
cord-266423-s8lqdpvn	5	38	onset	onset	NN
cord-266423-s8lqdpvn	5	39	of	of	IN
cord-266423-s8lqdpvn	5	40	widespread	widespread	JJ
cord-266423-s8lqdpvn	5	41	inflammation	inflammation	NN
cord-266423-s8lqdpvn	5	42	in	in	IN
cord-266423-s8lqdpvn	5	43	the	the	DT
cord-266423-s8lqdpvn	5	44	lungs	lung	NNS
cord-266423-s8lqdpvn	5	45	and	and	CC
cord-266423-s8lqdpvn	5	46	is	be	VBZ
cord-266423-s8lqdpvn	5	47	usually	usually	RB
cord-266423-s8lqdpvn	5	48	the	the	DT
cord-266423-s8lqdpvn	5	49	result	result	NN
cord-266423-s8lqdpvn	5	50	of	of	IN
cord-266423-s8lqdpvn	5	51	infectious	infectious	JJ
cord-266423-s8lqdpvn	5	52	or	or	CC
cord-266423-s8lqdpvn	5	53	chemical	chemical	JJ
cord-266423-s8lqdpvn	5	54	injury	injury	NN
cord-266423-s8lqdpvn	5	55	.	.	.
cord-266423-s8lqdpvn	6	1	The	the	DT
cord-266423-s8lqdpvn	6	2	obesity	obesity	NN
cord-266423-s8lqdpvn	6	3	paradox	paradox	NN
cord-266423-s8lqdpvn	6	4	in	in	IN
cord-266423-s8lqdpvn	6	5	ARDS	ARDS	NNP
cord-266423-s8lqdpvn	6	6	patients	patient	NNS
cord-266423-s8lqdpvn	6	7	has	have	VBZ
cord-266423-s8lqdpvn	6	8	been	be	VBN
cord-266423-s8lqdpvn	6	9	investigated	investigate	VBN
cord-266423-s8lqdpvn	6	10	by	by	IN
cord-266423-s8lqdpvn	6	11	Ni	Ni	NNP
cord-266423-s8lqdpvn	6	12	et	et	NNP
cord-266423-s8lqdpvn	6	13	al,1	al,1	NNP
cord-266423-s8lqdpvn	6	14	who	who	WP
cord-266423-s8lqdpvn	6	15	conclude	conclude	VBP
cord-266423-s8lqdpvn	6	16	that	that	IN
cord-266423-s8lqdpvn	6	17	obesity	obesity	NN
cord-266423-s8lqdpvn	6	18	and	and	CC
cord-266423-s8lqdpvn	6	19	morbid	morbid	JJ
cord-266423-s8lqdpvn	6	20	obesity	obesity	NN
cord-266423-s8lqdpvn	6	21	were	be	VBD
cord-266423-s8lqdpvn	6	22	associated	associate	VBN
cord-266423-s8lqdpvn	6	23	with	with	IN
cord-266423-s8lqdpvn	6	24	a	a	DT
cord-266423-s8lqdpvn	6	25	lower	low	JJR
cord-266423-s8lqdpvn	6	26	mortality	mortality	NN
cord-266423-s8lqdpvn	6	27	rate	rate	NN
cord-266423-s8lqdpvn	6	28	in	in	IN
cord-266423-s8lqdpvn	6	29	patients	patient	NNS
cord-266423-s8lqdpvn	6	30	with	with	IN
cord-266423-s8lqdpvn	6	31	ARDS	ARDS	NNP
cord-266423-s8lqdpvn	6	32	.	.	.
cord-266423-s8lqdpvn	7	1	We	-PRON-	PRP
cord-266423-s8lqdpvn	7	2	are	be	VBP
cord-266423-s8lqdpvn	7	3	writing	write	VBG
cord-266423-s8lqdpvn	7	4	in	in	IN
cord-266423-s8lqdpvn	7	5	reference	reference	NN
cord-266423-s8lqdpvn	7	6	to	to	IN
cord-266423-s8lqdpvn	7	7	the	the	DT
cord-266423-s8lqdpvn	7	8	editorial	editorial	JJ
cord-266423-s8lqdpvn	7	9	"	"	``
cord-266423-s8lqdpvn	7	10	COVID	COVID	NNP
cord-266423-s8lqdpvn	7	11	19	19	CD
cord-266423-s8lqdpvn	7	12	and	and	CC
cord-266423-s8lqdpvn	7	13	the	the	DT
cord-266423-s8lqdpvn	7	14	Patient	Patient	NNP
cord-266423-s8lqdpvn	7	15	with	with	IN
cord-266423-s8lqdpvn	7	16	Obesity	obesity	NN
cord-266423-s8lqdpvn	8	1	-The	-The	NFP
cord-266423-s8lqdpvn	8	2	Editors	editor	NNS
cord-266423-s8lqdpvn	8	3	Speak	speak	VBP
cord-266423-s8lqdpvn	8	4	Out	out	RP
cord-266423-s8lqdpvn	8	5	"	"	''
cord-266423-s8lqdpvn	8	6	(	(	-LRB-
cord-266423-s8lqdpvn	8	7	1	1	CD
cord-266423-s8lqdpvn	8	8	)	)	-RRB-
cord-266423-s8lqdpvn	8	9	.	.	.
cord-266423-s8lqdpvn	9	1	Obesity	obesity	NN
cord-266423-s8lqdpvn	9	2	is	be	VBZ
cord-266423-s8lqdpvn	9	3	associated	associate	VBN
cord-266423-s8lqdpvn	9	4	with	with	IN
cord-266423-s8lqdpvn	9	5	a	a	DT
cord-266423-s8lqdpvn	9	6	decrease	decrease	NN
cord-266423-s8lqdpvn	9	7	in	in	IN
cord-266423-s8lqdpvn	9	8	mortality	mortality	NN
cord-266423-s8lqdpvn	9	9	in	in	IN
cord-266423-s8lqdpvn	9	10	patients	patient	NNS
cord-266423-s8lqdpvn	9	11	with	with	IN
cord-266423-s8lqdpvn	9	12	acute	acute	JJ
cord-266423-s8lqdpvn	9	13	respiratory	respiratory	JJ
cord-266423-s8lqdpvn	9	14	distress	distress	NN
cord-266423-s8lqdpvn	9	15	syndrome	syndrome	NN
cord-266423-s8lqdpvn	9	16	(	(	-LRB-
cord-266423-s8lqdpvn	9	17	ARDS	ARDS	NNP
cord-266423-s8lqdpvn	9	18	)	)	-RRB-
cord-266423-s8lqdpvn	9	19	and	and	CC
cord-266423-s8lqdpvn	9	20	this	this	DT
cord-266423-s8lqdpvn	9	21	is	be	VBZ
cord-266423-s8lqdpvn	9	22	referred	refer	VBN
cord-266423-s8lqdpvn	9	23	to	to	IN
cord-266423-s8lqdpvn	9	24	as	as	IN
cord-266423-s8lqdpvn	9	25	the	the	DT
cord-266423-s8lqdpvn	9	26	obesity	obesity	NN
cord-266423-s8lqdpvn	9	27	paradox	paradox	NN
cord-266423-s8lqdpvn	9	28	(	(	-LRB-
cord-266423-s8lqdpvn	9	29	2	2	CD
cord-266423-s8lqdpvn	9	30	)	)	-RRB-
cord-266423-s8lqdpvn	9	31	.	.	.
cord-266423-s8lqdpvn	10	1	ARDS	ARDS	NNP
cord-266423-s8lqdpvn	10	2	is	be	VBZ
cord-266423-s8lqdpvn	10	3	a	a	DT
cord-266423-s8lqdpvn	10	4	type	type	NN
cord-266423-s8lqdpvn	10	5	of	of	IN
cord-266423-s8lqdpvn	10	6	respiratory	respiratory	JJ
cord-266423-s8lqdpvn	10	7	failure	failure	NN
cord-266423-s8lqdpvn	10	8	characterized	characterize	VBN
cord-266423-s8lqdpvn	10	9	by	by	IN
cord-266423-s8lqdpvn	10	10	rapid	rapid	JJ
cord-266423-s8lqdpvn	10	11	onset	onset	NN
cord-266423-s8lqdpvn	10	12	of	of	IN
cord-266423-s8lqdpvn	10	13	widespread	widespread	JJ
cord-266423-s8lqdpvn	10	14	inflammation	inflammation	NN
cord-266423-s8lqdpvn	10	15	in	in	IN
cord-266423-s8lqdpvn	10	16	the	the	DT
cord-266423-s8lqdpvn	10	17	lungs	lung	NNS
cord-266423-s8lqdpvn	10	18	and	and	CC
cord-266423-s8lqdpvn	10	19	is	be	VBZ
cord-266423-s8lqdpvn	10	20	usually	usually	RB
cord-266423-s8lqdpvn	10	21	the	the	DT
cord-266423-s8lqdpvn	10	22	result	result	NN
cord-266423-s8lqdpvn	10	23	of	of	IN
cord-266423-s8lqdpvn	10	24	infectious	infectious	JJ
cord-266423-s8lqdpvn	10	25	or	or	CC
cord-266423-s8lqdpvn	10	26	chemical	chemical	JJ
cord-266423-s8lqdpvn	10	27	injury	injury	NN
cord-266423-s8lqdpvn	10	28	.	.	.
cord-266423-s8lqdpvn	11	1	The	the	DT
cord-266423-s8lqdpvn	11	2	obesity	obesity	NN
cord-266423-s8lqdpvn	11	3	paradox	paradox	NN
cord-266423-s8lqdpvn	11	4	in	in	IN
cord-266423-s8lqdpvn	11	5	patients	patient	NNS
cord-266423-s8lqdpvn	11	6	with	with	IN
cord-266423-s8lqdpvn	11	7	ARDS	ARDS	NNP
cord-266423-s8lqdpvn	11	8	has	have	VBZ
cord-266423-s8lqdpvn	11	9	been	be	VBN
cord-266423-s8lqdpvn	11	10	investigated	investigate	VBN
cord-266423-s8lqdpvn	11	11	by	by	IN
cord-266423-s8lqdpvn	11	12	Ni	Ni	NNP
cord-266423-s8lqdpvn	11	13	et	et	NNP
cord-266423-s8lqdpvn	11	14	al	al	NNP
cord-266423-s8lqdpvn	11	15	.	.	.
cord-266423-s8lqdpvn	12	1	(	(	-LRB-
cord-266423-s8lqdpvn	12	2	2	2	LS
cord-266423-s8lqdpvn	12	3	)	)	-RRB-
cord-266423-s8lqdpvn	12	4	,	,	,
cord-266423-s8lqdpvn	12	5	who	who	WP
cord-266423-s8lqdpvn	12	6	conclude	conclude	VBP
cord-266423-s8lqdpvn	12	7	that	that	IN
cord-266423-s8lqdpvn	12	8	obesity	obesity	NN
cord-266423-s8lqdpvn	12	9	and	and	CC
cord-266423-s8lqdpvn	12	10	morbid	morbid	JJ
cord-266423-s8lqdpvn	12	11	obesity	obesity	NN
cord-266423-s8lqdpvn	12	12	were	be	VBD
cord-266423-s8lqdpvn	12	13	associated	associate	VBN
cord-266423-s8lqdpvn	12	14	with	with	IN
cord-266423-s8lqdpvn	12	15	a	a	DT
cord-266423-s8lqdpvn	12	16	lower	low	JJR
cord-266423-s8lqdpvn	12	17	mortality	mortality	NN
cord-266423-s8lqdpvn	12	18	rate	rate	NN
cord-266423-s8lqdpvn	12	19	in	in	IN
cord-266423-s8lqdpvn	12	20	patients	patient	NNS
cord-266423-s8lqdpvn	12	21	with	with	IN
cord-266423-s8lqdpvn	12	22	ARDS	ARDS	NNP
cord-266423-s8lqdpvn	12	23	.	.	.
cord-266423-s8lqdpvn	13	1	One	one	CD
cord-266423-s8lqdpvn	13	2	pathophysiological	pathophysiological	JJ
cord-266423-s8lqdpvn	13	3	mechanism	mechanism	NN
cord-266423-s8lqdpvn	13	4	postulated	postulate	VBN
cord-266423-s8lqdpvn	13	5	to	to	TO
cord-266423-s8lqdpvn	13	6	explain	explain	VB
cord-266423-s8lqdpvn	13	7	the	the	DT
cord-266423-s8lqdpvn	13	8	decreased	decreased	JJ
cord-266423-s8lqdpvn	13	9	mortality	mortality	NN
cord-266423-s8lqdpvn	13	10	in	in	IN
cord-266423-s8lqdpvn	13	11	critically	critically	RB
cord-266423-s8lqdpvn	13	12	ill	ill	JJ
cord-266423-s8lqdpvn	13	13	patients	patient	NNS
cord-266423-s8lqdpvn	13	14	with	with	IN
cord-266423-s8lqdpvn	13	15	obesity	obesity	NN
cord-266423-s8lqdpvn	13	16	is	be	VBZ
cord-266423-s8lqdpvn	13	17	preconditioning	precondition	VBG
cord-266423-s8lqdpvn	13	18	,	,	,
cord-266423-s8lqdpvn	13	19	a	a	DT
cord-266423-s8lqdpvn	13	20	chronic	chronic	JJ
cord-266423-s8lqdpvn	13	21	pro	pro	JJ
cord-266423-s8lqdpvn	13	22	-	-	JJ
cord-266423-s8lqdpvn	13	23	inflammatory	inflammatory	JJ
cord-266423-s8lqdpvn	13	24	status	status	NN
cord-266423-s8lqdpvn	13	25	in	in	IN
cord-266423-s8lqdpvn	13	26	obesity	obesity	NN
cord-266423-s8lqdpvn	13	27	that	that	WDT
cord-266423-s8lqdpvn	13	28	creates	create	VBZ
cord-266423-s8lqdpvn	13	29	a	a	DT
cord-266423-s8lqdpvn	13	30	protective	protective	JJ
cord-266423-s8lqdpvn	13	31	environment	environment	NN
cord-266423-s8lqdpvn	13	32	,	,	,
cord-266423-s8lqdpvn	13	33	limiting	limit	VBG
cord-266423-s8lqdpvn	13	34	the	the	DT
cord-266423-s8lqdpvn	13	35	detrimental	detrimental	JJ
cord-266423-s8lqdpvn	13	36	effects	effect	NNS
cord-266423-s8lqdpvn	13	37	of	of	IN
cord-266423-s8lqdpvn	13	38	a	a	DT
cord-266423-s8lqdpvn	13	39	more	more	RBR
cord-266423-s8lqdpvn	13	40	aggressive	aggressive	JJ
cord-266423-s8lqdpvn	13	41	second	second	JJ
cord-266423-s8lqdpvn	13	42	hit	hit	NN
cord-266423-s8lqdpvn	13	43	,	,	,
cord-266423-s8lqdpvn	13	44	such	such	JJ
cord-266423-s8lqdpvn	13	45	as	as	IN
cord-266423-s8lqdpvn	13	46	ventilatorinduced	ventilatorinduced	NNP
cord-266423-s8lqdpvn	13	47	lung	lung	NN
cord-266423-s8lqdpvn	13	48	injury	injury	NN
cord-266423-s8lqdpvn	13	49	or	or	CC
cord-266423-s8lqdpvn	13	50	sepsis	sepsis	NN
cord-266423-s8lqdpvn	13	51	(	(	-LRB-
cord-266423-s8lqdpvn	13	52	3	3	CD
cord-266423-s8lqdpvn	13	53	)	)	-RRB-
cord-266423-s8lqdpvn	13	54	.	.	.
cord-266423-s8lqdpvn	14	1	Patients	patient	NNS
cord-266423-s8lqdpvn	14	2	were	be	VBD
cord-266423-s8lqdpvn	14	3	further	further	RB
cord-266423-s8lqdpvn	14	4	divided	divide	VBN
cord-266423-s8lqdpvn	14	5	into	into	IN
cord-266423-s8lqdpvn	14	6	a	a	DT
cord-266423-s8lqdpvn	14	7	nonsurvivor	nonsurvivor	NNP
cord-266423-s8lqdpvn	14	8	group	group	NN
cord-266423-s8lqdpvn	14	9	(	(	-LRB-
cord-266423-s8lqdpvn	14	10	n	n	NN
cord-266423-s8lqdpvn	14	11	=	=	SYM
cord-266423-s8lqdpvn	14	12	17	17	CD
cord-266423-s8lqdpvn	14	13	)	)	-RRB-
cord-266423-s8lqdpvn	14	14	and	and	CC
cord-266423-s8lqdpvn	14	15	a	a	DT
cord-266423-s8lqdpvn	14	16	survivor	survivor	NN
cord-266423-s8lqdpvn	14	17	group	group	NN
cord-266423-s8lqdpvn	14	18	(	(	-LRB-
cord-266423-s8lqdpvn	14	19	n	n	NN
cord-266423-s8lqdpvn	14	20	=	=	SYM
cord-266423-s8lqdpvn	14	21	95	95	CD
cord-266423-s8lqdpvn	14	22	)	)	-RRB-
cord-266423-s8lqdpvn	14	23	.	.	.
cord-266423-s8lqdpvn	15	1	Among	among	IN
cord-266423-s8lqdpvn	15	2	the	the	DT
cord-266423-s8lqdpvn	15	3	nonsurvivors	nonsurvivor	NNS
cord-266423-s8lqdpvn	15	4	,	,	,
cord-266423-s8lqdpvn	15	5	88.2	88.2	CD
cord-266423-s8lqdpvn	15	6	%	%	NN
cord-266423-s8lqdpvn	15	7	(	(	-LRB-
cord-266423-s8lqdpvn	15	8	15	15	CD
cord-266423-s8lqdpvn	15	9	of	of	IN
cord-266423-s8lqdpvn	15	10	17	17	CD
cord-266423-s8lqdpvn	15	11	)	)	-RRB-
cord-266423-s8lqdpvn	15	12	of	of	IN
cord-266423-s8lqdpvn	15	13	patients	patient	NNS
cord-266423-s8lqdpvn	15	14	had	have	VBD
cord-266423-s8lqdpvn	15	15	BMI	BMI	NNP
cord-266423-s8lqdpvn	15	16	>	>	XX
cord-266423-s8lqdpvn	16	1	25	25	CD
cord-266423-s8lqdpvn	16	2	kg	kg	NNS
cord-266423-s8lqdpvn	16	3	/	/	SYM
cord-266423-s8lqdpvn	16	4	m	m	NN
cord-266423-s8lqdpvn	16	5	2	2	CD
cord-266423-s8lqdpvn	16	6	,	,	,
cord-266423-s8lqdpvn	16	7	which	which	WDT
cord-266423-s8lqdpvn	16	8	was	be	VBD
cord-266423-s8lqdpvn	16	9	significantly	significantly	RB
cord-266423-s8lqdpvn	16	10	higher	high	JJR
cord-266423-s8lqdpvn	16	11	than	than	IN
cord-266423-s8lqdpvn	16	12	that	that	DT
cord-266423-s8lqdpvn	16	13	of	of	IN
cord-266423-s8lqdpvn	16	14	survivors	survivor	NNS
cord-266423-s8lqdpvn	16	15	(	(	-LRB-
cord-266423-s8lqdpvn	16	16	18.9	18.9	CD
cord-266423-s8lqdpvn	16	17	%	%	NN
cord-266423-s8lqdpvn	16	18	(	(	-LRB-
cord-266423-s8lqdpvn	16	19	18	18	CD
cord-266423-s8lqdpvn	16	20	of	of	IN
cord-266423-s8lqdpvn	16	21	95	95	CD
cord-266423-s8lqdpvn	16	22	)	)	-RRB-
cord-266423-s8lqdpvn	16	23	,	,	,
cord-266423-s8lqdpvn	16	24	P	p	NN
cord-266423-s8lqdpvn	16	25	<	<	XX
cord-266423-s8lqdpvn	16	26	0.001	0.001	CD
cord-266423-s8lqdpvn	16	27	)	)	-RRB-
cord-266423-s8lqdpvn	16	28	.	.	.
cord-266423-s8lqdpvn	17	1	Wu	Wu	NNP
cord-266423-s8lqdpvn	17	2	et	et	NNP
cord-266423-s8lqdpvn	17	3	al	al	NNP
cord-266423-s8lqdpvn	17	4	.	.	.
cord-266423-s8lqdpvn	18	1	(	(	-LRB-
cord-266423-s8lqdpvn	18	2	5	5	LS
cord-266423-s8lqdpvn	18	3	)	)	-RRB-
cord-266423-s8lqdpvn	18	4	found	find	VBD
cord-266423-s8lqdpvn	18	5	that	that	IN
cord-266423-s8lqdpvn	18	6	a	a	DT
cord-266423-s8lqdpvn	18	7	group	group	NN
cord-266423-s8lqdpvn	18	8	with	with	IN
cord-266423-s8lqdpvn	18	9	severe	severe	JJ
cord-266423-s8lqdpvn	18	10	COVID-19	COVID-19	NNP
cord-266423-s8lqdpvn	18	11	had	have	VBD
cord-266423-s8lqdpvn	18	12	significantly	significantly	RB
cord-266423-s8lqdpvn	18	13	higher	high	JJR
cord-266423-s8lqdpvn	18	14	mean	mean	JJ
cord-266423-s8lqdpvn	18	15	BMI	BMI	NNP
cord-266423-s8lqdpvn	18	16	values	value	NNS
cord-266423-s8lqdpvn	18	17	than	than	IN
cord-266423-s8lqdpvn	18	18	a	a	DT
cord-266423-s8lqdpvn	18	19	group	group	NN
cord-266423-s8lqdpvn	18	20	of	of	IN
cord-266423-s8lqdpvn	18	21	patients	patient	NNS
cord-266423-s8lqdpvn	18	22	with	with	IN
cord-266423-s8lqdpvn	18	23	mild	mild	JJ
cord-266423-s8lqdpvn	18	24	disease	disease	NN
cord-266423-s8lqdpvn	18	25	(	(	-LRB-
cord-266423-s8lqdpvn	19	1	25.8	25.8	CD
cord-266423-s8lqdpvn	19	2	±	±	CD
cord-266423-s8lqdpvn	19	3	1.8	1.8	CD
cord-266423-s8lqdpvn	19	4	vs.	vs.	IN
cord-266423-s8lqdpvn	19	5	23.6	23.6	CD
cord-266423-s8lqdpvn	19	6	±	±	CD
cord-266423-s8lqdpvn	19	7	3.2	3.2	CD
cord-266423-s8lqdpvn	19	8	kg	kg	NNP
cord-266423-s8lqdpvn	19	9	/	/	SYM
cord-266423-s8lqdpvn	19	10	m	m	NN
cord-266423-s8lqdpvn	19	11	2	2	CD
cord-266423-s8lqdpvn	19	12	,	,	,
cord-266423-s8lqdpvn	19	13	P	p	NN
cord-266423-s8lqdpvn	19	14	=	=	SYM
cord-266423-s8lqdpvn	19	15	0.005	0.005	CD
cord-266423-s8lqdpvn	19	16	)	)	-RRB-
cord-266423-s8lqdpvn	20	1	.	.	.
cord-266423-s8lqdpvn	21	1	What	what	WP
cord-266423-s8lqdpvn	21	2	could	could	MD
cord-266423-s8lqdpvn	21	3	be	be	VB
cord-266423-s8lqdpvn	21	4	causing	cause	VBG
cord-266423-s8lqdpvn	21	5	the	the	DT
cord-266423-s8lqdpvn	21	6	apparent	apparent	JJ
cord-266423-s8lqdpvn	21	7	difference	difference	NN
cord-266423-s8lqdpvn	21	8	in	in	IN
cord-266423-s8lqdpvn	21	9	the	the	DT
cord-266423-s8lqdpvn	21	10	severity	severity	NN
cord-266423-s8lqdpvn	21	11	of	of	IN
cord-266423-s8lqdpvn	21	12	COVID-19	COVID-19	NNP
cord-266423-s8lqdpvn	21	13	in	in	IN
cord-266423-s8lqdpvn	21	14	patients	patient	NNS
cord-266423-s8lqdpvn	21	15	with	with	IN
cord-266423-s8lqdpvn	21	16	obesity	obesity	NN
cord-266423-s8lqdpvn	21	17	compared	compare	VBN
cord-266423-s8lqdpvn	21	18	with	with	IN
cord-266423-s8lqdpvn	21	19	previous	previous	JJ
cord-266423-s8lqdpvn	21	20	studies	study	NNS
cord-266423-s8lqdpvn	21	21	of	of	IN
cord-266423-s8lqdpvn	21	22	ARDS	ARDS	NNP
cord-266423-s8lqdpvn	21	23	in	in	IN
cord-266423-s8lqdpvn	21	24	patients	patient	NNS
cord-266423-s8lqdpvn	21	25	with	with	IN
cord-266423-s8lqdpvn	21	26	obesity	obesity	NN
cord-266423-s8lqdpvn	21	27	?	?	.
cord-266423-s8lqdpvn	22	1	Clinicians	clinician	NNS
cord-266423-s8lqdpvn	22	2	tend	tend	VBP
cord-266423-s8lqdpvn	22	3	to	to	TO
cord-266423-s8lqdpvn	22	4	consider	consider	VB
cord-266423-s8lqdpvn	22	5	patients	patient	NNS
cord-266423-s8lqdpvn	22	6	with	with	IN
cord-266423-s8lqdpvn	22	7	obesity	obesity	NN
cord-266423-s8lqdpvn	22	8	at	at	IN
cord-266423-s8lqdpvn	22	9	higher	high	JJR
cord-266423-s8lqdpvn	22	10	risk	risk	NN
cord-266423-s8lqdpvn	22	11	of	of	IN
cord-266423-s8lqdpvn	22	12	worse	bad	JJR
cord-266423-s8lqdpvn	22	13	outcomes	outcome	NNS
cord-266423-s8lqdpvn	22	14	;	;	:
cord-266423-s8lqdpvn	22	15	thus	thus	RB
cord-266423-s8lqdpvn	22	16	,	,	,
cord-266423-s8lqdpvn	22	17	this	this	DT
cord-266423-s8lqdpvn	22	18	might	may	MD
cord-266423-s8lqdpvn	22	19	result	result	VB
cord-266423-s8lqdpvn	22	20	in	in	IN
cord-266423-s8lqdpvn	22	21	earlier	early	JJR
cord-266423-s8lqdpvn	22	22	admission	admission	NN
cord-266423-s8lqdpvn	22	23	to	to	IN
cord-266423-s8lqdpvn	22	24	the	the	DT
cord-266423-s8lqdpvn	22	25	intensive	intensive	JJ
cord-266423-s8lqdpvn	22	26	care	care	NN
cord-266423-s8lqdpvn	22	27	unit	unit	NN
cord-266423-s8lqdpvn	22	28	for	for	IN
cord-266423-s8lqdpvn	22	29	monitoring	monitor	VBG
cord-266423-s8lqdpvn	22	30	purposes	purpose	NNS
cord-266423-s8lqdpvn	22	31	in	in	IN
cord-266423-s8lqdpvn	22	32	normal	normal	JJ
cord-266423-s8lqdpvn	22	33	circumstances	circumstance	NNS
cord-266423-s8lqdpvn	22	34	(	(	-LRB-
cord-266423-s8lqdpvn	22	35	6	6	CD
cord-266423-s8lqdpvn	22	36	)	)	-RRB-
cord-266423-s8lqdpvn	22	37	.	.	.
cord-266423-s8lqdpvn	23	1	In	in	IN
cord-266423-s8lqdpvn	23	2	this	this	DT
cord-266423-s8lqdpvn	23	3	current	current	JJ
cord-266423-s8lqdpvn	23	4	pandemic	pandemic	NN
cord-266423-s8lqdpvn	23	5	,	,	,
cord-266423-s8lqdpvn	23	6	clinicians	clinician	NNS
cord-266423-s8lqdpvn	23	7	are	be	VBP
cord-266423-s8lqdpvn	23	8	not	not	RB
cord-266423-s8lqdpvn	23	9	afforded	afford	VBN
cord-266423-s8lqdpvn	23	10	this	this	DT
cord-266423-s8lqdpvn	23	11	luxury	luxury	NN
cord-266423-s8lqdpvn	23	12	.	.	.
cord-266423-s8lqdpvn	24	1	Patients	patient	NNS
cord-266423-s8lqdpvn	24	2	with	with	IN
cord-266423-s8lqdpvn	24	3	obesity	obesity	NN
cord-266423-s8lqdpvn	24	4	have	have	VBP
cord-266423-s8lqdpvn	24	5	reduced	reduce	VBN
cord-266423-s8lqdpvn	24	6	chest	chest	NN
cord-266423-s8lqdpvn	24	7	-	-	HYPH
cord-266423-s8lqdpvn	24	8	wall	wall	NN
cord-266423-s8lqdpvn	24	9	elastance	elastance	NN
cord-266423-s8lqdpvn	24	10	and	and	CC
cord-266423-s8lqdpvn	24	11	lower	low	JJR
cord-266423-s8lqdpvn	24	12	total	total	JJ
cord-266423-s8lqdpvn	24	13	respiratory	respiratory	JJ
cord-266423-s8lqdpvn	24	14	system	system	NN
cord-266423-s8lqdpvn	24	15	compliance	compliance	NN
cord-266423-s8lqdpvn	24	16	,	,	,
cord-266423-s8lqdpvn	24	17	with	with	IN
cord-266423-s8lqdpvn	24	18	a	a	DT
cord-266423-s8lqdpvn	24	19	decreased	decrease	VBN
cord-266423-s8lqdpvn	24	20	expiratory	expiratory	NNP
cord-266423-s8lqdpvn	24	21	reserve	reserve	NN
cord-266423-s8lqdpvn	24	22	volume	volume	NN
cord-266423-s8lqdpvn	24	23	.	.	.
cord-266423-s8lqdpvn	25	1	Difficult	difficult	JJ
cord-266423-s8lqdpvn	25	2	airway	airway	NN
cord-266423-s8lqdpvn	25	3	management	management	NN
cord-266423-s8lqdpvn	25	4	,	,	,
cord-266423-s8lqdpvn	25	5	as	as	RB
cord-266423-s8lqdpvn	25	6	well	well	RB
cord-266423-s8lqdpvn	25	7	as	as	IN
cord-266423-s8lqdpvn	25	8	this	this	DT
cord-266423-s8lqdpvn	25	9	altered	altered	JJ
cord-266423-s8lqdpvn	25	10	lung	lung	NN
cord-266423-s8lqdpvn	25	11	and	and	CC
cord-266423-s8lqdpvn	25	12	chest	chest	NN
cord-266423-s8lqdpvn	25	13	-	-	HYPH
cord-266423-s8lqdpvn	25	14	wall	wall	NN
cord-266423-s8lqdpvn	25	15	physiology	physiology	NN
cord-266423-s8lqdpvn	25	16	,	,	,
cord-266423-s8lqdpvn	25	17	in	in	IN
cord-266423-s8lqdpvn	25	18	combination	combination	NN
cord-266423-s8lqdpvn	25	19	with	with	IN
cord-266423-s8lqdpvn	25	20	positional	positional	JJ
cord-266423-s8lqdpvn	25	21	gas	gas	NN
cord-266423-s8lqdpvn	25	22	trapping	trapping	NN
cord-266423-s8lqdpvn	25	23	is	be	VBZ
cord-266423-s8lqdpvn	25	24	routinely	routinely	RB
cord-266423-s8lqdpvn	25	25	encountered	encounter	VBN
cord-266423-s8lqdpvn	25	26	in	in	IN
cord-266423-s8lqdpvn	25	27	patients	patient	NNS
cord-266423-s8lqdpvn	25	28	with	with	IN
cord-266423-s8lqdpvn	25	29	obesity	obesity	NN
cord-266423-s8lqdpvn	25	30	(	(	-LRB-
cord-266423-s8lqdpvn	25	31	6	6	CD
cord-266423-s8lqdpvn	25	32	)	)	-RRB-
cord-266423-s8lqdpvn	25	33	.	.	.
cord-266423-s8lqdpvn	26	1	Proning	prone	VBG
cord-266423-s8lqdpvn	26	2	appears	appear	VBZ
cord-266423-s8lqdpvn	26	3	to	to	TO
cord-266423-s8lqdpvn	26	4	be	be	VB
cord-266423-s8lqdpvn	26	5	critical	critical	JJ
cord-266423-s8lqdpvn	26	6	to	to	IN
cord-266423-s8lqdpvn	26	7	success	success	NN
cord-266423-s8lqdpvn	26	8	in	in	IN
cord-266423-s8lqdpvn	26	9	ARDS	ARDS	NNP
cord-266423-s8lqdpvn	26	10	,	,	,
cord-266423-s8lqdpvn	26	11	which	which	WDT
cord-266423-s8lqdpvn	26	12	is	be	VBZ
cord-266423-s8lqdpvn	26	13	likely	likely	JJ
cord-266423-s8lqdpvn	26	14	to	to	TO
cord-266423-s8lqdpvn	26	15	be	be	VB
cord-266423-s8lqdpvn	26	16	difficult	difficult	JJ
cord-266423-s8lqdpvn	26	17	in	in	IN
cord-266423-s8lqdpvn	26	18	patients	patient	NNS
cord-266423-s8lqdpvn	26	19	with	with	IN
cord-266423-s8lqdpvn	26	20	obesity	obesity	NN
cord-266423-s8lqdpvn	26	21	because	because	IN
cord-266423-s8lqdpvn	26	22	of	of	IN
cord-266423-s8lqdpvn	26	23	staff	staff	NN
cord-266423-s8lqdpvn	26	24	and	and	CC
cord-266423-s8lqdpvn	26	25	equipment	equipment	NN
cord-266423-s8lqdpvn	26	26	shortages	shortage	NNS
cord-266423-s8lqdpvn	26	27	in	in	IN
cord-266423-s8lqdpvn	26	28	this	this	DT
cord-266423-s8lqdpvn	26	29	pandemic	pandemic	NN
cord-266423-s8lqdpvn	26	30	situation	situation	NN
cord-266423-s8lqdpvn	26	31	.	.	.
cord-266423-s8lqdpvn	27	1	Furthermore	furthermore	RB
cord-266423-s8lqdpvn	27	2	,	,	,
cord-266423-s8lqdpvn	27	3	right	right	JJ
cord-266423-s8lqdpvn	27	4	ventricular	ventricular	NN
cord-266423-s8lqdpvn	27	5	(	(	-LRB-
cord-266423-s8lqdpvn	27	6	7	7	CD
cord-266423-s8lqdpvn	27	7	)	)	-RRB-
cord-266423-s8lqdpvn	27	8	dysfunction	dysfunction	NN
cord-266423-s8lqdpvn	27	9	seems	seem	VBZ
cord-266423-s8lqdpvn	27	10	to	to	TO
cord-266423-s8lqdpvn	27	11	be	be	VB
cord-266423-s8lqdpvn	27	12	an	an	DT
cord-266423-s8lqdpvn	27	13	issue	issue	NN
cord-266423-s8lqdpvn	27	14	in	in	IN
cord-266423-s8lqdpvn	27	15	patients	patient	NNS
cord-266423-s8lqdpvn	27	16	with	with	IN
cord-266423-s8lqdpvn	27	17	COVID-19	COVID-19	NNP
cord-266423-s8lqdpvn	27	18	,	,	,
cord-266423-s8lqdpvn	27	19	and	and	CC
cord-266423-s8lqdpvn	27	20	patients	patient	NNS
cord-266423-s8lqdpvn	27	21	with	with	IN
cord-266423-s8lqdpvn	27	22	obesity	obesity	NN
cord-266423-s8lqdpvn	27	23	may	may	MD
cord-266423-s8lqdpvn	27	24	be	be	VB
cord-266423-s8lqdpvn	27	25	at	at	IN
cord-266423-s8lqdpvn	27	26	increased	increase	VBN
cord-266423-s8lqdpvn	27	27	risk	risk	NN
cord-266423-s8lqdpvn	27	28	because	because	IN
cord-266423-s8lqdpvn	27	29	of	of	IN
cord-266423-s8lqdpvn	27	30	impaired	impaired	JJ
cord-266423-s8lqdpvn	27	31	right	right	JJ
cord-266423-s8lqdpvn	27	32	ventricular	ventricular	JJ
cord-266423-s8lqdpvn	27	33	contraction	contraction	NN
cord-266423-s8lqdpvn	27	34	due	due	IN
cord-266423-s8lqdpvn	27	35	to	to	IN
cord-266423-s8lqdpvn	27	36	higher	high	JJR
cord-266423-s8lqdpvn	27	37	circulating	circulate	VBG
cord-266423-s8lqdpvn	27	38	plasma	plasma	NN
cord-266423-s8lqdpvn	27	39	volume	volume	NN
cord-266423-s8lqdpvn	27	40	,	,	,
cord-266423-s8lqdpvn	27	41	increased	increase	VBN
cord-266423-s8lqdpvn	27	42	sympathetic	sympathetic	JJ
cord-266423-s8lqdpvn	27	43	nervous	nervous	JJ
cord-266423-s8lqdpvn	27	44	system	system	NN
cord-266423-s8lqdpvn	27	45	activation	activation	NN
cord-266423-s8lqdpvn	27	46	,	,	,
cord-266423-s8lqdpvn	27	47	and	and	CC
cord-266423-s8lqdpvn	27	48	metabolic	metabolic	JJ
cord-266423-s8lqdpvn	27	49	dysregulation	dysregulation	NN
cord-266423-s8lqdpvn	27	50	driving	drive	VBG
cord-266423-s8lqdpvn	27	51	higher	high	JJR
cord-266423-s8lqdpvn	27	52	filling	filling	NN
cord-266423-s8lqdpvn	27	53	pressures	pressure	NNS
cord-266423-s8lqdpvn	27	54	.	.	.
cord-266423-s8lqdpvn	28	1	We	-PRON-	PRP
cord-266423-s8lqdpvn	28	2	do	do	VBP
cord-266423-s8lqdpvn	28	3	not	not	RB
cord-266423-s8lqdpvn	28	4	know	know	VB
cord-266423-s8lqdpvn	28	5	whether	whether	IN
cord-266423-s8lqdpvn	28	6	the	the	DT
cord-266423-s8lqdpvn	28	7	obesity	obesity	NN
cord-266423-s8lqdpvn	28	8	paradox	paradox	NN
cord-266423-s8lqdpvn	28	9	has	have	VBZ
cord-266423-s8lqdpvn	28	10	been	be	VBN
cord-266423-s8lqdpvn	28	11	broken	break	VBN
cord-266423-s8lqdpvn	28	12	by	by	IN
cord-266423-s8lqdpvn	28	13	COVID-19	COVID-19	NNP
cord-266423-s8lqdpvn	28	14	.	.	.
cord-266423-s8lqdpvn	29	1	Patients	patient	NNS
cord-266423-s8lqdpvn	29	2	with	with	IN
cord-266423-s8lqdpvn	29	3	obesity	obesity	NN
cord-266423-s8lqdpvn	29	4	may	may	MD
cord-266423-s8lqdpvn	29	5	be	be	VB
cord-266423-s8lqdpvn	29	6	less	less	RBR
cord-266423-s8lqdpvn	29	7	affected	affect	VBN
cord-266423-s8lqdpvn	29	8	by	by	IN
cord-266423-s8lqdpvn	29	9	aspects	aspect	NNS
cord-266423-s8lqdpvn	29	10	of	of	IN
cord-266423-s8lqdpvn	29	11	COVID-19	COVID-19	NNP
cord-266423-s8lqdpvn	29	12	,	,	,
cord-266423-s8lqdpvn	29	13	harder	hard	JJR
cord-266423-s8lqdpvn	29	14	to	to	TO
cord-266423-s8lqdpvn	29	15	treat	treat	VB
cord-266423-s8lqdpvn	29	16	because	because	IN
cord-266423-s8lqdpvn	29	17	of	of	IN
cord-266423-s8lqdpvn	29	18	obesity	obesity	NN
cord-266423-s8lqdpvn	29	19	-	-	HYPH
cord-266423-s8lqdpvn	29	20	related	relate	VBN
cord-266423-s8lqdpvn	29	21	factors	factor	NNS
cord-266423-s8lqdpvn	29	22	,	,	,
cord-266423-s8lqdpvn	29	23	and	and	CC
cord-266423-s8lqdpvn	29	24	at	at	IN
cord-266423-s8lqdpvn	29	25	greater	great	JJR
cord-266423-s8lqdpvn	29	26	risk	risk	NN
cord-266423-s8lqdpvn	29	27	because	because	IN
cord-266423-s8lqdpvn	29	28	of	of	IN
cord-266423-s8lqdpvn	29	29	obesity	obesity	NN
cord-266423-s8lqdpvn	29	30	-	-	HYPH
cord-266423-s8lqdpvn	29	31	relayed	relay	VBN
cord-266423-s8lqdpvn	29	32	vulnerabilities	vulnerability	NNS
cord-266423-s8lqdpvn	29	33	.	.	.
cord-266423-s8lqdpvn	30	1	Taken	take	VBN
cord-266423-s8lqdpvn	30	2	together	together	RB
cord-266423-s8lqdpvn	30	3	,	,	,
cord-266423-s8lqdpvn	30	4	these	these	DT
cord-266423-s8lqdpvn	30	5	elements	element	NNS
cord-266423-s8lqdpvn	30	6	may	may	MD
cord-266423-s8lqdpvn	30	7	contribute	contribute	VB
cord-266423-s8lqdpvn	30	8	to	to	IN
cord-266423-s8lqdpvn	30	9	difficulties	difficulty	NNS
cord-266423-s8lqdpvn	30	10	for	for	IN
cord-266423-s8lqdpvn	30	11	patients	patient	NNS
cord-266423-s8lqdpvn	30	12	with	with	IN
cord-266423-s8lqdpvn	30	13	obesity	obesity	NN
cord-266423-s8lqdpvn	30	14	in	in	IN
cord-266423-s8lqdpvn	30	15	accessing	access	VBG
cord-266423-s8lqdpvn	30	16	care	care	NN
cord-266423-s8lqdpvn	30	17	during	during	IN
cord-266423-s8lqdpvn	30	18	a	a	DT
cord-266423-s8lqdpvn	30	19	pandemic	pandemic	NN
cord-266423-s8lqdpvn	30	20	if	if	IN
cord-266423-s8lqdpvn	30	21	they	-PRON-	PRP
cord-266423-s8lqdpvn	30	22	are	be	VBP
cord-266423-s8lqdpvn	30	23	wrongly	wrongly	RB
cord-266423-s8lqdpvn	30	24	perceived	perceive	VBN
cord-266423-s8lqdpvn	30	25	by	by	IN
cord-266423-s8lqdpvn	30	26	clinicians	clinician	NNS
cord-266423-s8lqdpvn	30	27	and	and	CC
cord-266423-s8lqdpvn	30	28	policy	policy	NN
cord-266423-s8lqdpvn	30	29	makers	maker	NNS
cord-266423-s8lqdpvn	30	30	to	to	TO
cord-266423-s8lqdpvn	30	31	be	be	VB
cord-266423-s8lqdpvn	30	32	at	at	IN
cord-266423-s8lqdpvn	30	33	a	a	DT
cord-266423-s8lqdpvn	30	34	higher	high	JJR
cord-266423-s8lqdpvn	30	35	risk	risk	NN
cord-266423-s8lqdpvn	30	36	for	for	IN
cord-266423-s8lqdpvn	30	37	worse	bad	JJR
cord-266423-s8lqdpvn	30	38	outcomes	outcome	NNS
cord-266423-s8lqdpvn	30	39	.	.	.
cord-266423-s8lqdpvn	31	1	O	o	UH
cord-266423-s8lqdpvn	31	2	COVID	COVID	NNP
cord-266423-s8lqdpvn	31	3	19	19	CD
cord-266423-s8lqdpvn	31	4	and	and	CC
cord-266423-s8lqdpvn	31	5	the	the	DT
cord-266423-s8lqdpvn	31	6	patient	patient	NN
cord-266423-s8lqdpvn	31	7	with	with	IN
cord-266423-s8lqdpvn	31	8	obesity	obesity	NN
cord-266423-s8lqdpvn	32	1	-the	-the	DT
cord-266423-s8lqdpvn	32	2	editors	editor	NNS
cord-266423-s8lqdpvn	32	3	speak	speak	VBP
cord-266423-s8lqdpvn	32	4	out	out	RP
cord-266423-s8lqdpvn	33	1	Can	Can	MD
cord-266423-s8lqdpvn	33	2	body	body	VB
cord-266423-s8lqdpvn	33	3	mass	mass	NN
cord-266423-s8lqdpvn	33	4	index	index	NN
cord-266423-s8lqdpvn	33	5	predict	predict	VB
cord-266423-s8lqdpvn	33	6	clinical	clinical	JJ
cord-266423-s8lqdpvn	33	7	outcomes	outcome	NNS
cord-266423-s8lqdpvn	33	8	for	for	IN
cord-266423-s8lqdpvn	33	9	patients	patient	NNS
cord-266423-s8lqdpvn	33	10	with	with	IN
cord-266423-s8lqdpvn	33	11	acute	acute	JJ
cord-266423-s8lqdpvn	33	12	lung	lung	NN
cord-266423-s8lqdpvn	33	13	injury/	injury/	HYPH
cord-266423-s8lqdpvn	33	14	acute	acute	JJ
cord-266423-s8lqdpvn	33	15	respiratory	respiratory	JJ
cord-266423-s8lqdpvn	33	16	distress	distress	NN
cord-266423-s8lqdpvn	33	17	syndrome	syndrome	NN
cord-266423-s8lqdpvn	33	18	?	?	.
cord-266423-s8lqdpvn	34	1	A	a	DT
cord-266423-s8lqdpvn	34	2	meta	meta	JJ
cord-266423-s8lqdpvn	34	3	-	-	HYPH
cord-266423-s8lqdpvn	34	4	analysis	analysis	NN
cord-266423-s8lqdpvn	34	5	Adipose	Adipose	NNP
cord-266423-s8lqdpvn	34	6	-	-	HYPH
cord-266423-s8lqdpvn	34	7	lung	lung	NN
cord-266423-s8lqdpvn	34	8	cell	cell	NN
cord-266423-s8lqdpvn	34	9	crosstalk	crosstalk	NN
cord-266423-s8lqdpvn	34	10	in	in	IN
cord-266423-s8lqdpvn	34	11	the	the	DT
cord-266423-s8lqdpvn	34	12	obesity	obesity	NN
cord-266423-s8lqdpvn	34	13	-	-	HYPH
cord-266423-s8lqdpvn	34	14	ARDS	ARDS	NNP
cord-266423-s8lqdpvn	34	15	paradox	paradox	NN
cord-266423-s8lqdpvn	34	16	Clinical	clinical	JJ
cord-266423-s8lqdpvn	34	17	characteristics	characteristic	NNS
cord-266423-s8lqdpvn	34	18	and	and	CC
cord-266423-s8lqdpvn	34	19	outcomes	outcome	NNS
cord-266423-s8lqdpvn	34	20	of	of	IN
cord-266423-s8lqdpvn	34	21	112	112	CD
cord-266423-s8lqdpvn	34	22	cardiovascular	cardiovascular	JJ
cord-266423-s8lqdpvn	34	23	disease	disease	NN
cord-266423-s8lqdpvn	34	24	patients	patient	NNS
cord-266423-s8lqdpvn	34	25	infected	infect	VBN
cord-266423-s8lqdpvn	34	26	by	by	IN
cord-266423-s8lqdpvn	34	27	2019-nCoV	2019-ncov	CD
cord-266423-s8lqdpvn	34	28	Early	early	JJ
cord-266423-s8lqdpvn	34	29	antiviral	antiviral	JJ
cord-266423-s8lqdpvn	34	30	treatment	treatment	NN
cord-266423-s8lqdpvn	34	31	contributes	contribute	VBZ
cord-266423-s8lqdpvn	34	32	to	to	TO
cord-266423-s8lqdpvn	34	33	alleviate	alleviate	VB
cord-266423-s8lqdpvn	34	34	the	the	DT
cord-266423-s8lqdpvn	34	35	severity	severity	NN
cord-266423-s8lqdpvn	34	36	and	and	CC
cord-266423-s8lqdpvn	34	37	improve	improve	VB
cord-266423-s8lqdpvn	34	38	the	the	DT
cord-266423-s8lqdpvn	34	39	prognosis	prognosis	NN
cord-266423-s8lqdpvn	34	40	of	of	IN
cord-266423-s8lqdpvn	34	41	patients	patient	NNS
cord-266423-s8lqdpvn	34	42	with	with	IN
cord-266423-s8lqdpvn	34	43	novel	novel	JJ
cord-266423-s8lqdpvn	34	44	coronavirus	coronavirus	NN
cord-266423-s8lqdpvn	34	45	disease	disease	NN
cord-266423-s8lqdpvn	34	46	(	(	-LRB-
cord-266423-s8lqdpvn	34	47	COVID-19	covid-19	VB
cord-266423-s8lqdpvn	34	48	)	)	-RRB-
cord-266423-s8lqdpvn	35	1	Perioperative	perioperative	JJ
cord-266423-s8lqdpvn	35	2	management	management	NN
cord-266423-s8lqdpvn	35	3	of	of	IN
cord-266423-s8lqdpvn	35	4	obese	obese	JJ
cord-266423-s8lqdpvn	35	5	patients	patient	NNS
cord-266423-s8lqdpvn	35	6	How	how	WRB
cord-266423-s8lqdpvn	35	7	to	to	TO
cord-266423-s8lqdpvn	35	8	ventilate	ventilate	VB
cord-266423-s8lqdpvn	35	9	COVID-19	covid-19	CD
cord-266423-s8lqdpvn	35	10	patients	patient	NNS
cord-266423-s8lqdpvn	35	11	.	.	.
cord-266423-s8lqdpvn	36	1	European	European	NNP
cord-266423-s8lqdpvn	36	2	Society	Society	NNP
cord-266423-s8lqdpvn	36	3	of	of	IN
cord-266423-s8lqdpvn	36	4	Intensive	Intensive	NNP
cord-266423-s8lqdpvn	36	5	Care	Care	NNP
cord-266423-s8lqdpvn	36	6	Medicine	Medicine	NNP
cord-266423-s8lqdpvn	36	7	webinar	webinar	NN